Molecular basis for several drug-induced nephropathies

The American Journal of Medicine

Volumn 62, Issue 4, 1977, Pages 518-526

  Mitchell, Jerry R ^a   McMurtry, Randolph J ^a   Statham, Charles N ^a   Nelson, Sidney D ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; BARBITURIC ACID DERIVATIVE; CARBON TETRACHLORIDE; CARCINOGEN; CEFALORIDINE; CEPHALOSPORIN; CHLOROFORM; CYTOCHROME P450; DIURETIC AGENT; DRUG METABOLITE; ENZYME; FUROSEMIDE; KIDNEY ENZYME; METAL; NITROFURANTOIN; PARACETAMOL; SALICYLIC ACID; SALICYLIC ACID DERIVATIVE; TOXIC SUBSTANCE;

ACUTE KIDNEY FAILURE; ADVERSE DRUG REACTION; ANALGESIC NEPHROPATHY; ANIMAL; DRUG METABOLISM; ETIOLOGY; EXPERIMENTAL ANIMAL; KIDNEY TUBULE NECROSIS; MODEL; NEPHROTOXICITY; PATHOGENESIS;

ACETAMINOPHEN; ANALGESICS; ANIMAL; CARBON TETRACHLORIDE POISONING; CEPHALORIDINE; CHLOROFORM; CYTOCHROME P-450 ENZYME SYSTEM; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FURANS; FUROSEMIDE; GLUTATHIONE; HUMAN; KIDNEY; KIDNEY DISEASES; KIDNEY TUBULAR NECROSIS, ACUTE; KIDNEY TUBULES, PROXIMAL; PROTEIN BINDING; SALICYLATES; TOXICOLOGY;

EID: 0017598349     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9343(77)90407-7     Document Type: Article

References (86)

1. Drug metabolism as a cause of drug toxicity
2. Biochemical basis for drug toxicity
3. Metabolic activation of drugs to toxic substances. Progress in hepatology
4. Metabolic activation. Biochemical basis for many drug-induced liver injuries
5. Editorial Paracetamol hepatotoxicity
6. Isoniazid liver injury. Clinical spectrum, pathology and probable pathogenesis
7. Acetaminophen-induced hepatic injury. Protective role of glutathione in humans and rationale for possible therapy
8. Cysteamine, methionine, and penicillamine in the treatment of paracetamol poisoning
9. The cytochrome P-450-containing mono-oxygenase system of rat kidney cortex microsomes
10. Development of mechanisms for drug excretion
11. Symposium on paracetamol and the liver. Overdosage and its management
12. Treatment of acute paracetamol poisoning
13. Acute paracetamol poisoning
14. Liver damage and impaired glucose tolerance after paracetamol overdose
15. Plasma-paracetamol half-life and hepatic necrosis in patients with paracetamol overdose
16. Acetaminophen-induced hepatic necrosis and renal failure
17. Liver necrosis from paracetamol
18. Experimental renal toxicity
19. Importance of dose-threshold for drug-induced tissue lesions
20. Metabolic activation of acetaminophen, cephaloridine and other chemically stable compounds to nephrotoxic metabolites
21. Acetaminopheninduced hepatic necrosis. I. Role of drug metabolism
22. Acetaminophen-induced hepatic necrosis. V. Correlation of hepatic necrosis, covalent binding and glutathione depletion in hamsters
23. Role of the liver in drug metabolism
24. Cytochrome P-450 and its role in drug metabolism
25. Some properties and distribution of the α-hydroxylation system of medium-chain fatty acids
26. The influence of some hepatic enzyme inducers and inhibitors on extrahepatic drug metabolism
27. The effect of cobalt chloride administration on the synthesis of hepatic microsomal cytochrome P-450
28. Inhibition of microsomal drug metabolism by methylene-dioxybenzenes
29. Cephaloridine therapy as related to renal function
30. Cephaloridine studies of therapeutic activity and untoward effects
31. Nephrotoxicity associated with the use of cephaloridine
32. Cephaloridine, cephalothin and the kidney
33. The effect of cephaloridine on normal renal function
34. Nephrotoxicity due to cephaloridine
35. Nephron transport and renal tubular effects of cephaloridine in animals
36. Acute renal failure during cephalothin therapy
37. Pharmacology and toxicology of cephalosporins
38. Toxic nephropathy
39. 125l-diatrizoate
40. The comparative metabolism of phenacetin and N-acetyl-p-aminophenol in man, with particular reference to effects on the kidney
41. Salicylates and renal function in rheumatoid arthritis
42. Bartter's syndrome: a disorder characterized by high urinary prostaglandins and a dependence of hyperreninemia on prostaglandin synthesis
43. Prostaglandins: effects on blood pressure, renal blood flow, sodium and water excretion
44. Aspirin and the kidney
45. Effect of aspirin on liver tests in patients with RA or SLE and in normal volunteers
46. The short-term effects of analgesics on the kidney with special reference to acetylsalicylic acid
47. Oxidation of α-methyldopa and other catechols by cytochrome P-450-generated superoxide anion: possible mechanism of methyldopa hepatitis
48. Allergic interstitial nephritis causing reversible renal failure in four patients with idiopathic nephrotic syndrome
49. Hepatic necrosis caused by furosemide
50. Metabolic activation of furosemide to a chemically reactive, hepatotoxic metabolite
51. Role of metabolic activation in the pathogenesis of chemically induced pulmonary disease; mechanism of action of lung-toxic furan 4-ipomeanol
52. Chloroform toxicity in mice: correlation of renal and hepatic necrosis with covalent binding of metabolites to tissue macromolecules
53. Carbon tetrachloride hepatotoxicity: an example of lethal cleavage
54. Differences in the potentiation of carbon tetrachloride in rats by ethanol and isopropanol pretreatment
55. Die chronisch-interstitielle Nephritis
56. Relation between regular intake of phenacetin-containing analgesics and laboratory evidence for urorenal disorders in a working female population of Switzerland
57. Phenacetin-containing analgesics and chronic renal disease
58. Analgesic nephropathy—a review of the literature, 1967–1970
59. Analgesic abuse and renal disease
60. Pathogenesis of the renal lesion associated with the abuse of analgesics
61. The evolution of analgesic nephropathy
62. Renal accumulation of salicylate and phenacetin: possible mechanisms in the nephropathy of analgesic abuse
63. Analgesic nephropathy: renal distribution of acetaminophen and its conjugates
64. Phenacetin renal tubular transport and intrarenal distribution in the dog
65. Syndrome associated with the abuse of analgesics
66. The association of peptic ulceration, chronic renal disease and analgesic abuse
67. Comparative nephrotoxicity of aspirin and phenacetin derivatives
68. Nephrotoxicity and molecular structure
69. Papillary necrosis in rats caused by aspirin and aspirin-containing mixtures
70. Acute necrotizing renal papillitis experimentally produced in rats fed mono-N-methylaniline
71. N-phenyl anthranilic acid: an agent for inducing and studying renal papillary necrosis in the rat
72. D'une necrose typique de la papille rénale determinée par la tetrahydroquinoléine and certains de ses derivés
73. The induction of renal papillary necrosis in Gunn rats by analgesics and analgesic mixtures
74. Some new aspects of the metabolism of phenacetin in the rat
75. N-hydroxyphenacetin as a precursor of 3-substituted 4-hydroxyacetanilide metabolites of phenacetin
76. N-hydroxylation of phenacetin by hamster liver microsomes
77. Neoplasia in the rat induced by N-hydroxyphenacetin, a metabolite of phenacetin
78. 2-ethyl]-labeled phenacetin
79. Usefulness of drug interactions in elucidating phenacetin and other drug-induced tissue injuries
80. Effect of variation in dietary NaCl intake on total and fractional renal blood flow in the normal and mercury-intoxicated rat